| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-09028-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81047-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-12027-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11977-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-34863-10ug | |||
| Carrier-Free | NBP2-34863-1mg | |||
| Carrier-Free | NBP2-34863-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52647-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11966-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-52656-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81044-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-81095-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier-Free | NBP2-35051-10ug | |||
| Carrier-Free | NBP2-35051-1mg | |||
| Carrier-Free | NBP2-35051-500ug | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-75898SS | |||
![Western Blot: IL-2 Antibody (LNKB-2) [NBP2-81047] - Western Blot using anti-IL-2 antibody (LNKB-2) [NBP2-81047]. Untreated human peripheral blood monocyte (PBM) (A), PMA/lonomycin-treated PBM (B), human spleen (C), human thymus (D), Jurkat cell (E) and Molt4 cell (F) lysate samples (35ug protein in RIPA buffer) were resolved on a 15% SDS PAGE gel and blots probed with the rabbit IgG-chimeric version of LNKB-2 [NBP2-81047] at 1 ug/ml (A, B) or 0.1 ug/ml (C-F) before detection using an anti-rabbit secondary antibody. Protein was detected by chemiluminescence. The expected running size for IL-2 is 17.6kDa. NBP2-81047 successfully detected Il-2 in multiple human tissue / cell samples.](http://images.novusbio.com/fullsize/IL-2-Antibody-LNKB-2-Western-Blot-NBP2-81047-img0001.jpg "Western Blot: IL-2 Antibody (LNKB-2) [NBP2-81047] - Western Blot using anti-IL-2 antibody (LNKB-2) [NBP2-81047]. Untreated human peripheral blood monocyte (PBM) (A), PMA/lonomycin-treated PBM (B), human spleen (C), human thymus (D), Jurkat cell (E) and Molt4 cell (F) lysate samples (35ug protein in RIPA buffer) were resolved on a 15% SDS PAGE gel and blots probed with the rabbit IgG-chimeric version of LNKB-2 [NBP2-81047] at 1 ug/ml (A, B) or 0.1 ug/ml (C-F) before detection using an anti-rabbit secondary antibody. Protein was detected by chemiluminescence. The expected running size for IL-2 is 17.6kDa. NBP2-81047 successfully detected Il-2 in multiple human tissue / cell samples.")
![Immunocytochemistry/Immunofluorescence: B7-1/CD80 Antibody (16C10) - Chimeric [NBP3-12027] - Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 16C10 (NBP3-12027) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12027, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/B7-1-CD80-Antibody-16C10-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-12027-img0001.jpg "Immunocytochemistry/Immunofluorescence: B7-1/CD80 Antibody (16C10) - Chimeric [NBP3-12027] - Immunofluorescence analysis of paraformaldehyde fixed Daudi cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of 16C10 (NBP3-12027) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-12027, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Flow Cytometry: B7-1/CD80 Antibody (16C10) - Chimeric - Azide and BSA Free [NBP3-12027] - Daudi cells were fixed using 2% PFA and stained with anti-unknown specificity antibody (isotype control, black line) or NBP3-12027 (blue line) at a dilution of 1:100 for 1h at RT. After washing, the bound antibody was detected using a goat anti-rabbit IgG AlexaFluor 488 antibody at a dilution of 1:1000 and cells analyzed using a FACSCanto flow-cytometer.](http://images.novusbio.com/fullsize/nbp3-12027_rabbit-monoclonal-b7-1-cd80-antibody-16c10-chimeric-7420252211308.png)
![SDS-Page: Human IL-3 Protein [NBP2-34863]](http://images.novusbio.com/fullsize/Human-IL-3-Protein-SDS-Page-NBP2-34863-img0001.jpg "SDS-Page: Human IL-3 Protein [NBP2-34863]")
![Flow Cytometry: CD38 Antibody (HB7) - Chimeric [NBP2-52647] - CD38 Antibody (HB7) [NBP2-52647] - Flow Cytometry using anti-CD38 antibody HB7. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of HB7 (NBP2-52647, panel B) at a concentration of 1 ug/mL for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow cytometer.](http://images.novusbio.com/fullsize/CD38-Antibody-HB7-Chimeric-Flow-Cytometry-NBP2-52647-img0001.jpg "Flow Cytometry: CD38 Antibody (HB7) - Chimeric [NBP2-52647] - CD38 Antibody (HB7) [NBP2-52647] - Flow Cytometry using anti-CD38 antibody HB7. Human lymphocytes were stained with an isotype control (panel A) or the rabbit-chimeric version of HB7 (NBP2-52647, panel B) at a concentration of 1 ug/mL for 30 mins at RT. After washing, bound antibody was detected using a AF488 conjugated donkey anti-rabbit antibody and cells analysed on a FACSCanto flow cytometer.")
![ELISA: CTLA-4 Antibody (9H10) - Chimeric [NBP3-11966] - Binding curves of the rabbit chimeric version of the anti-CTLA-4 antibody 9H10 (NBP3-11966; red line) and isotype control (anti-Fluorescein antibody NBP2-52638 4-4-20 (enhanced); blue line) to an ELISA plate coated with mouse CTLA-4-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10,000 to 0.17 ng/ml was performed using NBP3-11966. For signal detection, a 1:4000 dilution of HRP-labelled anti-rabbit IgG1 antibody was used.](http://images.novusbio.com/fullsize/CTLA-4-Antibody-9H10-Chimeric-ELISA-NBP3-11966-img0001.jpg "ELISA: CTLA-4 Antibody (9H10) - Chimeric [NBP3-11966] - Binding curves of the rabbit chimeric version of the anti-CTLA-4 antibody 9H10 (NBP3-11966; red line) and isotype control (anti-Fluorescein antibody NBP2-52638 4-4-20 (enhanced); blue line) to an ELISA plate coated with mouse CTLA-4-Fc fusion protein at a concentration of 5 ug/ml. A 3-fold serial dilution from 10,000 to 0.17 ng/ml was performed using NBP3-11966. For signal detection, a 1:4000 dilution of HRP-labelled anti-rabbit IgG1 antibody was used.")
![Western Blot: IFN-gamma Antibody (D9D10) [NBP2-81044] - Western Blot using anti-IFN gamma antibody (D9D10) [NBP2-81044]. Human thymus lysate (35ug protein in RIPA buffer) was resolved on a 15% SDS PAGE gel and blots probed with the rabbit IgG-chimeric version of D9D10 [NBP2-81044] at 0.1 ug/ml before detection using an anti-rabbit secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for IFN gamma is 19.3kDa, though the form shown here is likely glycosylated. NBP2-81044 successfully detected IFN gamma in human thymus samples.](http://images.novusbio.com/fullsize/IFN-gamma-Antibody-D9D10-Western-Blot-NBP2-81044-img0001.jpg "Western Blot: IFN-gamma Antibody (D9D10) [NBP2-81044] - Western Blot using anti-IFN gamma antibody (D9D10) [NBP2-81044]. Human thymus lysate (35ug protein in RIPA buffer) was resolved on a 15% SDS PAGE gel and blots probed with the rabbit IgG-chimeric version of D9D10 [NBP2-81044] at 0.1 ug/ml before detection using an anti-rabbit secondary antibody. Protein was detected by chemiluminescence. The expected unmodified running size for IFN gamma is 19.3kDa, though the form shown here is likely glycosylated. NBP2-81044 successfully detected IFN gamma in human thymus samples.")
![Functional: Human IL1 alpha Protein [NBP2-35051]](http://images.novusbio.com/fullsize/Human-IL1-alpha-Protein-Functional-NBP2-35051-img0001.jpg "Functional: Human IL1 alpha Protein [NBP2-35051]")
![SDS-Page: Human IL-1 alpha/IL-1F1 Protein [NBP2-35051]](http://images.novusbio.com/fullsize/Human-IL-1-alpha-IL-1F1-Protein-SDS-Page-NBP2-35051-img0002.jpg)
![Western Blot: TNF-alpha Antibody (cA2 (Infliximab)) - Chimeric [NBP2-75898] - Mouse liver (lane 1), mouse spinal cord (lane 2), mouse testis (lane 3), mouse colon (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75898 at 1.5 ug/ml before being detected by a secondary antibody. The expected band size (269 kDa) is seen in the human-derived samples, as well as a band corresponding to dimers.](http://images.novusbio.com/fullsize/TNF-alpha-Antibody-cA2-Infliximab-Chimeric-Western-Blot-NBP2-75898-img0002.jpg "Western Blot: TNF-alpha Antibody (cA2 (Infliximab)) - Chimeric [NBP2-75898] - Mouse liver (lane 1), mouse spinal cord (lane 2), mouse testis (lane 3), mouse colon (lane 4) and human thyroid tumour (lane 5) samples were resolved on a 10% SDS PAGE gel and blots probed with NBP2-75898 at 1.5 ug/ml before being detected by a secondary antibody. The expected band size (269 kDa) is seen in the human-derived samples, as well as a band corresponding to dimers.")